Workers' Comp
A True Alternative to Opioids for Workers’ Comp? Questions Remain
March 10, 2025
MIN READ
More stories
Workers' Comp
Article
Implications of Epidiolex FDA Approval on Workers' Compensation
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
Workers' Comp
Blog
How Differences in Claim Age and Population Affect Opioid Trends
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
Mitchell
News Release
Illinois Piloting Opioid Alternative Cannabis Program
The Illinois Alternatives to Opioids Act of 2018 recently went into effect. Learn what this means for workers' compensation patients.
Workers' Comp
News Release
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
By Brian Allen, VP of Government Affairs
Mitchell
News Release
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo
Workers' Comp
Blog
Positive Compound Trends Continue in Work Comp
Utilization and costs associated with compound medications fell significantly for both managed and unmanaged claims in 2017.